The YAP/Hippo pathway has been well described to crosstalk with growth-promoting tumor-specific mutations, such as hyperactivating mutations in RAS/RAF/MAPK, which is further described in this review in the context of neuroblastoma. This evidence concerns the gene YAP1 and neuroblastoma.